翻訳と辞書 |
John Mendlein : ウィキペディア英語版 | John Mendlein
Dr. John Mendlein is a biotech executive and formerly CEO of Adnexus Therapeutics, a Boston, MA based biotech company founded by Flagship Ventures and acquired by Bristol-Myers Squibb for over $500M.〔()〕 He was formerly CEO of Affinium Pharmaceuticals. Prior to managing Affinium, Dr. Mendlein was the Chief Knowledge Officer at Aurora Biosciences, a company co-founded by Nobel laureate Roger Y. Tsien and since acquired by Vertex Pharmaceuticals. Under Dr. Mendlein's leadership, Adnexus was acquired by Bristol-Myers Squibb for roughly US$400M. After selling and leaving Adnexus, Dr. Meinlein became the Chairman of Fate Therapeutics, a stem cell company. In May 2010, he joined aTyr Pharma as Executive Chairman. ==References==
抄文引用元・出典: フリー百科事典『 ウィキペディア(Wikipedia)』 ■ウィキペディアで「John Mendlein」の詳細全文を読む
スポンサード リンク
翻訳と辞書 : 翻訳のためのインターネットリソース |
Copyright(C) kotoba.ne.jp 1997-2016. All Rights Reserved.
|
|